Profiel
Reinilde Heyrman is currently Chief Medical Officer at Medpace Holdings, Inc. since 2017.
Former positions include Chief Clinical Development Officer at Ikaria, Inc. and Secretary, Chief Clinical Development Officer & VP at Bellerophon Therapeutics, Inc. Education includes a doctorate from the University of Antwerp.
Actieve functies van Reinilde Heyrman
| Bedrijven | Functie | Begin |
|---|---|---|
| MEDPACE HOLDINGS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-09-2017 |
Eerdere bekende functies van Reinilde Heyrman
| Bedrijven | Functie | Einde |
|---|---|---|
| IKARIA, INC. | Corporate Officer/Principal | - |
| BELLEROPHON THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Reinilde Heyrman
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Ikaria, Inc.
Ikaria, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets therapeutics | Health Technology |
Bellerophon Therapeutics, Inc.
Bellerophon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing of pharmaceutical products to treat cardiopulmonary diseases | Health Technology |
University of Antwerp
University of Antwerp Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medpace Holdings, Inc.
Medpace Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a a clinical contract research organization company which provides scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries | Commercial Services |
















